EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating Quality Management and Diagnostics Microbiology Performance Within an International External Quality Assessment (EQA) Program Serving National One Health Sector Reference Laboratories Across Asia: Experience Amid the Coronavirus Disease 2019 (COVID-19) Pandemic

Freshwork Ayalew Abegaz, Patrícia Teixeira Dos Santos, Ondari D Mogeni, Tobin Guarnacci, Nimesh Poudyal, Jinhui Hong, Soo Young Kwon, Rikke Braae, Rangsiya Prathan, Taradon Luang Tongkum, Watcharaporn Kamjumpho, Rungtip Chuanchuen und 3 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciad569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Freshwork Ayalew Abegaz und 14 weiteren Autor:innen. Beteiligte Einrichtung: International Vaccine Institute, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: One Health, COVID-19, Anti-Infective Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fleming Fund Regional Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Strengthening external quality assessment (EQA) services across the One Health sector supports implementation of effective antimicrobial resistance (AMR) control strategies. Here we describe and compare 2 different approaches for conducting virtual laboratory follow-up assessments within an EQA program to evaluate quality management system (QMS) and procedures for pathogen identification and antimicrobial susceptibility testing (AST).

Methods

During the coronavirus disease 2019 (COVID-19) pandemic in 2021 and 2022, 2 laboratory assessment approaches were introduced: virtual-based and survey-based methodologies. The evaluation of 2 underperforming Animal Health laboratories through a virtual-based approach occurred between May and August 2021. This evaluation encompassed the utilization of 3 online meetings and document reviews, performed subsequent to the execution of EQA procedures. Within a distinct group of laboratories, the survey-based assessment was implemented from December 2021 to February 2022, also following EQA procedures. This phase encompassed the dissemination of an online survey to 31 participating laboratories, alongside a sole online consultation meeting involving 4 specific underperforming laboratories.

Results

The virtual-based assessment post-EQA aimed to identify gaps and areas for improvement in the laboratory's practices for pathogen identification and AST. This approach was, however, time-intensive, and, hence, only 2 laboratories were assessed. In addition, limited interactions in virtual platforms compromised the assessment quality. The survey-based post-EQA assessment enabled evaluation of 31 laboratories. Despite limitations for in-depth analysis of each procedure, gaps in QMS across multiple laboratories were identified and tailored laboratory-specific recommendations were provided.

Conclusions

Reliable internet and plans for efficient time management, post-EQA virtual laboratory follow-up assessments are an effective alternative when conducting onsite evaluation is infeasible as observed during the COVID-19 pandemic, although the successful implementation of remediation plans will likely require in person assessments. We advocate application of hybrid approaches (both onsite and virtual) for targeted capacity building of AMR procedures with the ability to implement and oversee the process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

One HealthCOVID-19Anti-Infective AgentsHumansQuality ControlLaboratoriesPandemicsAsiaQuality Assurance, Health CareCOVID-19 Testing

Stichwörter der Autor:innen

antimicrobial resistanceexternal quality assessmentone healthquality management systemremote assessment

Substanzen

Anti-Infective Agents

Autor:innen und Institutionen

  • International Vaccine Institute, Seoul, Republic of Korea.
  • The Technical University of Denmark, National Food Institute, WHO Collaborating Center for Antimicrobial Resistance in Foodborne Pathogens and Genomics and European Union Reference Laboratory for Antimicrobial Resistanc…
  • Research Unit for Microbial Food Safety and Antimicrobial Resistance, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
  • National Institute of Health, Bangkok, Thailand.
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
  • Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.

Förderung

  • Fleming Fund Regional Grant

Zitieren

APA

Abegaz, F. A., Dos Santos, P. T., Mogeni, O. D., Guarnacci, T., Poudyal, N., Hong, J., Kwon, S. Y., Braae, R., Prathan, R., Tongkum, T. L., Kamjumpho, W., Chuanchuen, R., Marks, F., Hendriksen, R. S., & Holm, M. (2023). Evaluating Quality Management and Diagnostics Microbiology Performance Within an International External Quality Assessment (EQA) Program Serving National One Health Sector Reference Laboratories Across Asia: Experience Amid the Coronavirus Disease 2019 (COVID-19) Pandemic. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad569

Vancouver

Abegaz FA, Dos Santos PT, Mogeni OD, Guarnacci T, Poudyal N, Hong J, et al. Evaluating Quality Management and Diagnostics Microbiology Performance Within an International External Quality Assessment (EQA) Program Serving National One Health Sector Reference Laboratories Across Asia: Experience Amid the Coronavirus Disease 2019 (COVID-19) Pandemic. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad569

BibTeX
@article{Abegaz2023,
  author = {Abegaz, Freshwork Ayalew and Dos Santos, Patrícia Teixeira and Mogeni, Ondari D and Guarnacci, Tobin and Poudyal, Nimesh and Hong, Jinhui and Kwon, Soo Young and Braae, Rikke and Prathan, Rangsiya and Tongkum, Taradon Luang and Kamjumpho, Watcharaporn and Chuanchuen, Rungtip and Marks, Florian and Hendriksen, Rene S and Holm, Marianne},
  title = {Evaluating Quality Management and Diagnostics Microbiology Performance Within an International External Quality Assessment (EQA) Program Serving National One Health Sector Reference Laboratories Across Asia: Experience Amid the Coronavirus Disease 2019 (COVID-19) Pandemic},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciad569}
}
Kostenlos starten →